Direct
NAV (24-Jul-24)
Returns (Since Inception)
Fund Size
₹14 Cr
Expense Ratio
1.62%
ISIN
INF740K01OE4
Minimum SIP
₹100
Exit Load
No Charges
Inception Date
31 Dec 2012
In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.
1 Year
-5.52%
— (Cat Avg.)
3 Years
-8.03%
— (Cat Avg.)
5 Years
+2.39%
— (Cat Avg.)
10 Years
+2.37%
— (Cat Avg.)
Since Inception
+3.89%
— (Cat Avg.)
Equity | ₹13.65 Cr | 97.18% |
Debt | ₹0 Cr | 0.03% |
Others | ₹0.39 Cr | 2.80% |
All Holdings
Equity
Debt & Others
Name | Type | Amount | Holdings |
---|---|---|---|
BGF Nutrition I2 | Mutual Fund - Open End | ₹13.91 Cr | 99.04% |
Treps / Reverse Repo Investment | Cash - Repurchase Agreement | ₹0.15 Cr | 1.08% |
Net Receivables/Payables | Cash | ₹-0.02 Cr | 0.12% |
Equity Sector
Debt & Others
Instruments | Amount | Holdings |
---|---|---|
Mutual Fund - Open End | ₹13.91 Cr | 99.04% |
Cash - Repurchase Agreement | ₹0.15 Cr | 1.08% |
Cash | ₹-0.02 Cr | 0.12% |
Standard Deviation
This fund
14.30%
Cat. avg.
--
Lower the better
Sharpe Ratio
This fund
-1.04
Cat. avg.
--
Higher the better
Sortino Ratio
This fund
--
Cat. avg.
--
Higher the better
Since March 2013
ISIN | INF740K01OE4 | Expense Ratio | 1.62% | Exit Load | No Charges | Fund Size | ₹14 Cr | Age | 31 Dec 2012 | Lumpsum Minimum | ₹100 | Fund Status | Open Ended Investment Company | Benchmark | MSCI ACWI NR USD |
To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.
Flat 15% tax on realised gains (STCG - short term capital gains)
10% tax on realised gains above Rs. 1 lakh per financial year (LTCG - long term capital gains)
Note: Mutual funds are subject to capital gains taxation with surcharge and cess, based on prevailing income tax rules and investor income. Taxation applies to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.
Fund name | Expense Ratio | Exit Load | Fund size | 1Y |
---|---|---|---|---|
Aditya Birla Sun Life Commodity Equity Global Agricultural Regular Growth Very High Risk | 1.7% | 1.0% | ₹13.04 Cr | -3.0% |
HSBC Asia Pacific (Ex Japan) Dividend Yield Fund Regular Growth Very High Risk | 2.0% | 1.0% | ₹6.31 Cr | 17.4% |
HSBC Asia Pacific (Ex Japan) Dividend Yield Fund Direct Growth Very High Risk | 1.6% | 1.0% | ₹6.31 Cr | 17.9% |
Franklin Asian Equity Fund Regular Growth Very High Risk | 2.5% | 1.0% | ₹244.25 Cr | 8.7% |
DSP Global Innovation Fund of Fund Direct Growth Very High Risk | 1.2% | 0.0% | ₹838.03 Cr | 25.7% |
DSP Global Innovation Fund of Fund Regular Growth Very High Risk | 2.0% | 0.0% | ₹838.03 Cr | 24.5% |
Aditya Birla Sun Life Global Emerging Opportunities Fund Regular Growth Very High Risk | 2.0% | 0.0% | ₹271.14 Cr | 17.7% |
Edelweiss US Value Equity Offshore Fund Regular Growth Very High Risk | 2.2% | 1.0% | ₹104.32 Cr | 12.2% |
Edelweiss US Value Equity Offshore Fund Direct Growth Very High Risk | 1.3% | 1.0% | ₹104.32 Cr | 13.2% |
ICICI Prudential Global Advantage Fund (FOF) Regular Growth Very High Risk | 2.1% | 1.0% | ₹308.16 Cr | 9.1% |
Total AUM
₹1,58,660 Cr
Address
West Wing, 11th Floor, Mumbai, 400021
Your principal amount will be at Very High Risk